Studies: Promising Cognitive and Imaging Results in Alzheimer’s and pre-dementia Patients
November 21, 2023 08:00 ET
|
Posit Science
SAN FRANCISCO, Nov. 21, 2023 (GLOBE NEWSWIRE) -- A pair of articles in the Journal of Alzheimer’s Disease (JAD) from researchers, who conducted a pilot study for the treatment of pre-dementia and...
RetinalGeniX™ Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs
November 09, 2023 12:58 ET
|
RetinalGeniX Technologies, Inc.
RetinalGeniX Announces Therapeutic Solutions Being Developed for Dry Age-Related Macular Degeneration
and Alzheimer’s Syndrome.
Encore Creativity for Older Adults Receives $1M Donation for Brain Health Initiatives
November 02, 2023 09:52 ET
|
Encore Creativity for Older Adults
Encore Creativity for Older Adults receives gift pledge of $1M to expand music programs for those with cognitive change
Breakthrough Study: Alzheimer’s Patients Benefit from Lifestyle Coaching (Not Drugs)
October 16, 2023 08:00 ET
|
Posit Science
Study shows lifestyle change by pre-dementia and Alzheimer's patients drove better cognitive performance than generally seen in trials of Alzheimer's drugs
Neuronic Welcomes Light Therapy Experts to its Scientific Advisory Board
August 31, 2023 10:00 ET
|
Neuronic Devices Operations GmbH
EGG HARBOR, N.J, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Neuronic, a pioneering company in the field of photobiomodulation (PBM) technology, also known as light therapy, is proud to announce the...
Cognition Therapeutics Announces Participation in Upcoming September Conferences
August 30, 2023 08:00 ET
|
Cognition Therapeutics, Inc.
PURCHASE, N.Y., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage neuroscience company developing drugs that treat neurodegenerative disorders by...
Athira Pharma Presents Phase 2 Clinical Data Correlating Improvements in Biomarkers of Neurodegeneration and Neuroinflammation with Improvements in Measures of Cognition and Function in Alzheimer’s Disease
July 17, 2023 07:00 ET
|
Athira Pharma, Inc.
New preclinical data demonstrate neuroprotective effects of fosgonimeton in models of amyloid-ß-mediated toxicity In preclinical models, ATH-1105 protects against pathologies common to amyotrophic...
DAVOS ALZHEIMER’S COLLABORATIVE SHARES ADVANCEMENT OF PREPARING HEALTHCARE SYSTEMS AND INCLUSIVE RESEARCH AT THE 2023 AAIC
July 12, 2023 19:15 ET
|
Davos Alzheimer's Collaborative
New York, NY, July 12, 2023 (GLOBE NEWSWIRE) -- DAC Healthcare System Preparedness poster presentations geared for timely detection from mobilizing community workers, adding pharmacies to the...
The Joint Commission, in Collaboration with the Alzheimer’s Association, Launches Memory Care Certification for Assisted Living Communities
July 11, 2023 12:30 ET
|
The Joint Commission
OAKBROOK TERRACE, Ill., July 11, 2023 (GLOBE NEWSWIRE) -- The Joint Commission, in collaboration with the Alzheimer’s Association, launched Memory Care Certification for Assisted Living Communities...
UsAgainstAlzheimer’s Applauds FDA Approval of Leqembi for Treatment of Early-Stage Alzheimer’s
July 06, 2023 17:35 ET
|
UsAgainstAlzheimer's
Washington, DC, July 06, 2023 (GLOBE NEWSWIRE) -- Patient advocacy organization UsAgainstAlzheimer’s today hailed the first-of-its-kind traditional approval by the Food and Drug Administration (FDA)...